(2020) Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic. Multiple Sclerosis and Related Disorders. ISSN 2211-0348
Full text not available from this repository.
Abstract
Favorable outcome after COVID-19 infection
| Item Type: | Article |
|---|---|
| Keywords: | COVID-19 Multiple sclerosis Ocrelizumab |
| Subjects: | WC Communicable Diseases > WC 500-590 Virus Diseases WL Nervous System |
| Divisions: | Faculty of Medicine > Departments of Clinical Sciences > Department of Neurology Isfahan Neurosciences Research Center |
| Journal or Publication Title: | Multiple Sclerosis and Related Disorders |
| Journal Index: | ISI |
| Volume: | 43 |
| Identification Number: | https://doi.org/10.1016/j.msard.2020.102222 |
| ISSN: | 2211-0348 |
| Depositing User: | Zahra Otroj |
| URI: | http://eprints.mui.ac.ir/id/eprint/12581 |
Actions (login required)
 |
View Item |